At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
CELZ Creative Medical Technology Holdings, Inc.
Closed 05-14 16:00:00 EDT
4.44
+0.11
+2.54%
盘后4.44
+0.000.00%
16:22 EDT
High4.76
Low4.33
Vol6.21K
Open4.76
D1 Closing4.33
Amplitude9.93%
Mkt Cap6.02M
Tradable Cap5.86M
Total Shares1.36M
T/O27.70K
T/O Rate0.47%
Tradable Shares1.32M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Creative Medical Technology Holdings Inc expected to post a loss of $1.16 a share - Earnings Preview
Creative Medical Technology Holdings (NASDAQ:CELZ) Granted FDA Clearance To Begin Phase 1/2 Clinical Trial Of AlloStem(TM) For Addressing Chronic Lower Back Pain
Creative Medical Technology Holdings, Inc., a biotechnology company, focuses on immunology, urology, orthopedics, and neurology using adult stem cell treatments. The company offers CaverStem to treat erectile dysfunction; FemCelz for the treatment of loss of genital sensitivity and dryness; StemSpine to treat chronic lower back pain; ImmCelz for the treatment of stroke patients; and OvaStem for treatment of female infertility. Creative Medical Technology Holdings, Inc. is based in Phoenix, Arizona.